2024年11月27日 · Bexarotene is used to treat skin lesions caused by a rare type of cancer called cutaneous T-cell lymphoma. Bexarotene is usually given after other treatments have failed. …

Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T cell lymphoma (CTCL). [4] It is a third-generation retinoid. [5] It was …

Bexarotene belongs to the group of medicines known as retinoids. It is used to treat a certain type of cancer called cutaneous T-cell lymphoma. It works by interfering with the growth of the …

Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma - CTCL). It belongs to a class of drugs called retinoids (vitamin A derivatives). …

Bexarotene is used to treat cutaneous T-cell lymphoma (CTCL, a type of lymphoma [cancer] that attacks the skin) in people whose disease could not be treated successfully with at least one …

Bexarotene treats the skin symptoms of cutaneous T-cell lymphoma. This is a rare blood cancer that causes a rash and very itchy skin. This medication comes as a capsule. You can take it …

2025年1月1日 · Topical bexarotene is commonly used to treat skin lesions (sores) in certain people with cutaneous T-cell lymphoma (CTCL), which is a type of cancer that is also known …

2005年5月15日 · What is bexarotene? Bexarotene is a medicine mainly used to treat cutaneous T-cell lymphoma (CTCL). It is not available in New Zealand. Indications for treatment with …

2001年5月1日 · Bexarotene is orally administered, safe, and generally well tolerated with reversible side effects, and is effective for the treatment of advanced, refractory CTCL. …

Targretin (bexarotene) capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy....